On this page · 4 sections→
Where the EU money came from
Funding by EU programme. Amounts are Regulaxis's own share of each project, not the project's full budget.
- Horizon 2020€2.2M · 2 projects
Projects
2 EU-funded projects, newest first. Regulaxis led 2 of them as coordinator. Each links to the official record.
- RHYPCoordinator
A new hope for early gonarthrosis treatment using a biotechnological therapeutic drug to regenerate cartilage by intra-articular knee injection
Horizon 2020 · 2017–2020 · Project on CORDIS ↗
€2.1Mtheir share - REGHACoordinator
Medical device combining viscosupplementation with pharmacological active molecule to regenerate cartilage in degenerative or traumatic osteoarthritis.
Horizon 2020 · 2015–2015 · Project on CORDIS ↗
€50ktheir share
Fields it works in
Research fields recorded on its Horizon projects.
- databases
- drug discovery
- pharmaceutical drugs
- surgery
- toxicology
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.